Mark D Hicar Selected Research

Mark D Hicar Research Topics

4	Mucocutaneous Lymph Node Syndrome (Kawasaki Disease) 12/2023 - 04/2019
4	Infections 01/2022 - 09/2008
3	COVID-19 12/2023 - 06/2020
2	Coronary Aneurysm (Aneurysm, Coronary) 04/2023 - 04/2019
2	Inflammation (Inflammations) 10/2022 - 05/2002
2	HIV Infections (HIV Infection) 01/2016 - 01/2015
1	Shock 12/2023
1	COVID-19 related pediatric multisystem inflammatory disease 12/2023
1	Abdominal Pain (Pain, Abdominal) 08/2023
1	Headache (Headaches) 08/2023
1	Virus Diseases (Viral Diseases) 04/2023
1	Aneurysm (Aneurysms) 04/2023
1	Dermatomyositis (Dermatopolymyositis) 01/2022
1	Myositis (Idiopathic Inflammatory Myopathies) 01/2022
1	Macrophage Activation Syndrome 01/2022
1	Ulcer 01/2022
1	Myocarditis (Carditis) 01/2021
1	Severe Acute Respiratory Syndrome 01/2021
1	Neoplasms (Cancer) 01/2021
1	Atrioventricular Block 01/2021
1	Malaria 07/2020
1	Persistent Infection 02/2016
1	Human Influenza (Influenza) 09/2008

6	AntibodiesIBA 10/2022 - 09/2008
4	Proteins (Proteins, Gene)FDA Link 04/2023 - 09/2008
3	VaccinesIBA 10/2022 - 07/2010
2	Biomarkers (Surrogate Marker)IBA 12/2023 - 01/2021
2	TroponinIBA 08/2023 - 01/2021
2	AutoantibodiesIBA 04/2023 - 01/2022
2	AntigensIBA 01/2022 - 07/2020
2	Peptides (Polypeptides)IBA 01/2021 - 07/2020
2	EpitopesIBA 02/2016 - 01/2016
1	pro-brain natriuretic peptide (1-76)IBA 12/2023
1	CreatinineIBA 08/2023
1	Hemoglobins (Hemoglobin)IBA 08/2023
1	Immunoconjugates (Immunoconjugate)IBA 04/2023
1	SteroidsIBA 01/2021
1	Immune Checkpoint InhibitorsIBA 01/2021
1	Troponin IIBA 01/2021
1	Liposomes (Liposome)IBA 07/2020
1	SilverIBA 06/2020
1	Intravenous Immunoglobulins (IVIG)FDA Link 04/2019
1	HIV AntibodiesIBA 02/2016
1	gag Gene Products (gag Protein)IBA 01/2015
1	Immunodominant EpitopesIBA 01/2015
1	Broadly Neutralizing AntibodiesIBA 07/2010
1	Neutralizing AntibodiesIBA 09/2008
1	lipopolysaccharide AIBA 05/2002

2	Therapeutics 01/2021 - 01/2021
1	Length of Stay 12/2023
1	Self-Help Devices (Assistive Technology) 01/2022